Giffin Daughtridge


Giffin is the co-founder and CEO of UrSure Inc., which makes diagnostic tests aimed at monitoring and improving medication adherence. To date, UrSure has raised $415,000 in nondilutive funding by winning the Harvard Business School’s New Venture Competition, the Harvard President’s Innovation Challenge, and receiving an NIH Small Business Innovation Research Grant.Giffin holds an MD form the Perelman School of Medicine at the University of Pennsylvania and an MPA from the Harvard Kennedy School where he was a Zuckerman Fellow in the Center for Public Leadership. He has been a Fulbright research scholar to Colombia, and he was recently named to the 2018 Forbes 30 under 30 list for healthcare.